×

Eli Lilly's Zyprexa Issues

9:10 AM ET Mon, 18 Dec 2006

Eli Lilly may have downplayed the risk of its top-selling schizophrenia drug - Zyprexa. Mike Huckman, CNBC Pharmaceuticals Reporter, and Erin Burnett discuss the details.